Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc. scores highest on Anchor (68) and lowest on Price (0). Its PosiPenta is 38.08 out of 100, weaker than most similar companies.
On the Penta Grid this week, Axsome Therapeutics, Inc. is Grid #600 of 837 in the Healthcare sector in United States, and Grid #3,061 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | 38.08 | 0 | 55 | 57 | 10 | 68 |
| AptarGroup, Inc. | 64.14 | 51 | 61 | 79 | 58 | 73 |
| TG Therapeutics, Inc. | 58.84 | 37 | 55 | 92 | 57 | 53 |
| Arrowhead Pharmaceuticals, Inc. | 32.15 | 4 | 18 | 60 | 27 | 53 |
| HealthEquity, Inc. | 64.75 | 36 | 84 | 81 | 58 | 65 |
| Spyre Therapeutics, Inc. | 45.10 | 10 | 21 | 78 | 76 | 40 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -42.02 |
| P/B ratio | 98.81 |
EEarnings
| Trailing EPS | ₹-354.23 |
| Forward EPS | ₹382.50 |
NNitro
| Price | 14883.51 |
| 52-week high | 24643.88 |
| 52-week low | 11697.30 |
| Fall from 52-week high | 39.6% |
TTorque
| Return on equity (ROE) | -245.10% |
| Debt-to-equity | 2.70 |
AAnchor
| Beta (price swings) | 0.85 |
| Market cap | ₹77,961 Cr |
| Insider holding | 15.08% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Axsome Therapeutics, Inc.'s PosiPenta score?
Axsome Therapeutics, Inc.'s PosiPenta is 38.08 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Axsome Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Axsome Therapeutics, Inc. is Grid #600 of 837 in the Healthcare sector in United States, and Grid #3,061 of 4,000 in United States.
Which PosiPenta pillar is strongest for Axsome Therapeutics, Inc.?
Anchor (stability and dividends), with a score of 68 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Axsome Therapeutics, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
Has Axsome Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 12.82 points, from 25.26 to 38.08.
PositoAI is for research and education only and is not investment advice.